Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment.
Saved in:
| Title: | Prime Editing, CRISPR-Cas9, and NanoCas Genome Editing for Cancer Treatment. |
|---|---|
| Authors: | Hossain H; Department of Anatomy and Histology, Sylhet Agricultural University, Sylhet, 3100, Bangladesh., Sayeed SSB; Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, 2202, Bangladesh., Islam S; Department of Anatomy and Histology, Sylhet Agricultural University, Sylhet, 3100, Bangladesh., Ahmad T; Department of Medicine, Sylhet Agricultural University, Sylhet, 3100, Bangladesh., Brishty KA; Department of Zoology (GSSC), University of Dhaka, Dhaka, 1000, Bangladesh., Chowdhury MSR; Department of Medicine, Sylhet Agricultural University, Sylhet, 3100, Bangladesh., Alam MS; Department of Microbiology, Gono Bishwabidyalay, Dhaka, 1344, Bangladesh., Mahmud MS; Department of Microbiology, Gono Bishwabidyalay, Dhaka, 1344, Bangladesh., Rahman MM; Department of Medicine, Sylhet Agricultural University, Sylhet, 3100, Bangladesh. mahfuj.vetmed@sau.ac.bd. |
| Source: | Molecular biotechnology [Mol Biotechnol] 2026 Jun; Vol. 68 (6), pp. 2630-2658. Date of Electronic Publication: 2026 Jan 06. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: Switzerland NLM ID: 9423533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0305 (Electronic) Linking ISSN: 10736085 NLM ISO Abbreviation: Mol Biotechnol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
